These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 16516910
1. Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes. Chaulet H, Lin F, Guo J, Owens WA, Michalicek J, Kesteven SH, Guan Z, Prall OW, Mearns BM, Feneley MP, Steinberg SF, Graham RM. J Mol Cell Cardiol; 2006 Apr; 40(4):540-52. PubMed ID: 16516910 [Abstract] [Full Text] [Related]
2. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction. Du XJ, Fang L, Gao XM, Kiriazis H, Feng X, Hotchkin E, Finch AM, Chaulet H, Graham RM. J Mol Cell Cardiol; 2004 Nov; 37(5):979-87. PubMed ID: 15522275 [Abstract] [Full Text] [Related]
10. Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function. Funakoshi H, Chan TO, Good JC, Libonati JR, Piuhola J, Chen X, MacDonnell SM, Lee LL, Herrmann DE, Zhang J, Martini J, Palmer TM, Sanbe A, Robbins J, Houser SR, Koch WJ, Feldman AM. Circulation; 2006 Nov 21; 114(21):2240-50. PubMed ID: 17088462 [Abstract] [Full Text] [Related]
12. Cardiomyocyte overexpression of the α1A-adrenergic receptor in the rat phenocopies second but not first window preconditioning. Zhao X, Park J, Ho D, Gao S, Yan L, Ge H, Iismaa S, Lin L, Tian B, Vatner DE, Graham RM, Vatner SF. Am J Physiol Heart Circ Physiol; 2012 Apr 15; 302(8):H1614-24. PubMed ID: 22307672 [Abstract] [Full Text] [Related]
13. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy. Zhai P, Galeotti J, Liu J, Holle E, Yu X, Wagner T, Sadoshima J. Circ Res; 2006 Sep 01; 99(5):528-36. PubMed ID: 16902180 [Abstract] [Full Text] [Related]
14. Transgenic overexpression of the secreted, extracellular EGF-CUB domain-containing protein SCUBE3 induces cardiac hypertrophy in mice. Yang HY, Cheng CF, Djoko B, Lian WS, Tu CF, Tsai MT, Chen YH, Chen CC, Cheng CJ, Yang RB. Cardiovasc Res; 2007 Jul 01; 75(1):139-47. PubMed ID: 17442284 [Abstract] [Full Text] [Related]
15. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC, Communal C, Singh K, Colucci W, Bristow MR, Port DJ. J Mol Cell Cardiol; 2000 May 01; 32(5):817-30. PubMed ID: 10775486 [Abstract] [Full Text] [Related]
17. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction. Kompa AR, See F, Lewis DA, Adrahtas A, Cantwell DM, Wang BH, Krum H. J Pharmacol Exp Ther; 2008 Jun 01; 325(3):741-50. PubMed ID: 18334667 [Abstract] [Full Text] [Related]
18. Gene expression profile of mouse myocardium with transgenic overexpression of A1 adenosine receptors. Lankford AR, Byford AM, Ashton KJ, French BA, Lee JK, Headrick JP, Matherne GP. Physiol Genomics; 2002 Oct 29; 11(2):81-9. PubMed ID: 12388787 [Abstract] [Full Text] [Related]